Ocumension Therapeutics (CIK 0001840315)

Latest company ownership

Shares held
100,221
Last filed at
Jan 16, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 11, 2024 Jan 16, 2024 EyePoint Pharmaceuticals, Inc. Director Sell 15.0 -1,910,500 -95.02% $37.2M
Dec 5, 2023 Dec 7, 2023 EyePoint Pharmaceuticals, Inc. Director Sell 15.0 -1,000,000 -33.21% $19.5M